nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—lung cancer—vascular cancer	0.976	1	CtDrD
Gefitinib—STK10—renal vein—vascular cancer	0.0129	0.85	CbGeAlD
Gefitinib—MKNK1—Signaling mediated by p38-alpha and p38-beta—MITF—vascular cancer	0.00108	0.117	CbGpPWpGaD
Gefitinib—MKNK2—cardiac atrium—vascular cancer	0.000655	0.0432	CbGeAlD
Gefitinib—MKNK1—cardiac atrium—vascular cancer	0.000647	0.0426	CbGeAlD
Gefitinib—LOC400927-CSNK1E—Wnt Signaling Pathway Netpath—TSC2—vascular cancer	0.000541	0.0589	CbGpPWpGaD
Gefitinib—MAP2K5—cardiac atrium—vascular cancer	0.000476	0.0313	CbGeAlD
Gefitinib—ALB—Scavenging of heme from plasma—HBA1—vascular cancer	0.000403	0.0438	CbGpPWpGaD
Gefitinib—CSNK1E—Wnt Signaling Pathway Netpath—TSC2—vascular cancer	0.000284	0.0309	CbGpPWpGaD
Gefitinib—ABCB1—blood vessel—vascular cancer	0.000282	0.0186	CbGeAlD
Gefitinib—CYP1A1—cardiac atrium—vascular cancer	0.00022	0.0145	CbGeAlD
Gefitinib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—vascular cancer	0.000161	0.0175	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.000156	0.017	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00015	0.0164	CbGpPWpGaD
Gefitinib—MKNK1—Signaling by FGFR—TSC2—vascular cancer	0.000147	0.016	CbGpPWpGaD
Gefitinib—ERBB3—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.000145	0.0158	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—WWTR1—vascular cancer	0.000143	0.0156	CbGpPWpGaD
Gefitinib—CHEK2—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.000141	0.0154	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—WWTR1—vascular cancer	0.00014	0.0152	CbGpPWpGaD
Gefitinib—MKNK1—Signaling by FGFR in disease—TSC2—vascular cancer	0.000137	0.0149	CbGpPWpGaD
Gefitinib—ALB—Vitamin B12 Metabolism—HBA1—vascular cancer	0.000135	0.0147	CbGpPWpGaD
Gefitinib—ERBB3—PI-3K cascade—TSC2—vascular cancer	0.00013	0.0142	CbGpPWpGaD
Gefitinib—ERBB3—PI3K/AKT activation—TSC2—vascular cancer	0.000127	0.0139	CbGpPWpGaD
Gefitinib—ERBB3—GAB1 signalosome—TSC2—vascular cancer	0.000126	0.0137	CbGpPWpGaD
Gefitinib—ERBB3—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.000123	0.0134	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—HBA1—vascular cancer	0.00011	0.0119	CbGpPWpGaD
Gefitinib—MAP2K5—BDNF signaling pathway—TSC2—vascular cancer	9.94e-05	0.0108	CbGpPWpGaD
Gefitinib—MKNK1—Disease—WWTR1—vascular cancer	9.79e-05	0.0107	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by SCF-KIT—TSC2—vascular cancer	9.75e-05	0.0106	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—WWTR1—vascular cancer	9.64e-05	0.0105	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling of activated FGFR—TSC2—vascular cancer	9.33e-05	0.0102	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB4—TSC2—vascular cancer	9.18e-05	0.00999	CbGpPWpGaD
Gefitinib—MAP2K5—Insulin Signaling—TSC2—vascular cancer	9.14e-05	0.00995	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signal transduction—TSC2—vascular cancer	8.77e-05	0.00954	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR—TSC2—vascular cancer	8.72e-05	0.0095	CbGpPWpGaD
Gefitinib—ALB—Selenium Micronutrient Network—HBA1—vascular cancer	8.72e-05	0.00949	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—TSC2—vascular cancer	8.68e-05	0.00945	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—TSC2—vascular cancer	8.64e-05	0.0094	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	8.51e-05	0.00927	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	8.37e-05	0.00911	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	8.13e-05	0.00885	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—TSC2—vascular cancer	8.13e-05	0.00885	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—TSC2—vascular cancer	8.13e-05	0.00885	CbGpPWpGaD
Gefitinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	8.06e-05	0.00877	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—TSC2—vascular cancer	8.05e-05	0.00877	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—TSC2—vascular cancer	7.98e-05	0.00869	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—TSC2—vascular cancer	7.95e-05	0.00865	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—WWTR1—vascular cancer	7.62e-05	0.00829	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—TSC2—vascular cancer	7.52e-05	0.00819	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	7.47e-05	0.00813	CbGpPWpGaD
Gefitinib—EGFR—PI-3K cascade—TSC2—vascular cancer	7.26e-05	0.0079	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	7.2e-05	0.00783	CbGpPWpGaD
Gefitinib—EGFR—PI3K/AKT activation—TSC2—vascular cancer	7.09e-05	0.00771	CbGpPWpGaD
Gefitinib—EGFR—GAB1 signalosome—TSC2—vascular cancer	7.03e-05	0.00765	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—CD34—vascular cancer	7e-05	0.00762	CbGpPWpGaD
Gefitinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	6.87e-05	0.00748	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—WWTR1—vascular cancer	6.86e-05	0.00747	CbGpPWpGaD
Gefitinib—ERBB3—Disease—WWTR1—vascular cancer	5.8e-05	0.00632	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—TSC2—vascular cancer	5.74e-05	0.00625	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—TSC2—vascular cancer	5.54e-05	0.00603	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TSC2—vascular cancer	5.46e-05	0.00594	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—TSC2—vascular cancer	5.43e-05	0.00591	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—WWTR1—vascular cancer	5.33e-05	0.00581	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD34—vascular cancer	5.33e-05	0.0058	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—TSC2—vascular cancer	5.19e-05	0.00565	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TSC2—vascular cancer	5.14e-05	0.00559	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—TSC2—vascular cancer	5.11e-05	0.00556	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—TSC2—vascular cancer	4.88e-05	0.00531	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—TSC2—vascular cancer	4.86e-05	0.00529	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—TSC2—vascular cancer	4.83e-05	0.00526	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—TSC2—vascular cancer	4.81e-05	0.00523	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	4.74e-05	0.00516	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—TSC2—vascular cancer	4.61e-05	0.00502	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	4.52e-05	0.00492	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—TSC2—vascular cancer	4.52e-05	0.00492	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—TSC2—vascular cancer	4.52e-05	0.00492	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—TSC2—vascular cancer	4.48e-05	0.00488	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—TSC2—vascular cancer	4.44e-05	0.00484	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—TSC2—vascular cancer	4.42e-05	0.00482	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD34—vascular cancer	4.25e-05	0.00462	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—WWTR1—vascular cancer	4.22e-05	0.00459	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—TSC2—vascular cancer	4.19e-05	0.00456	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—WWTR1—vascular cancer	4.06e-05	0.00442	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	4.01e-05	0.00436	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—TSC2—vascular cancer	3.96e-05	0.00431	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD34—vascular cancer	3.9e-05	0.00424	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	3.84e-05	0.00418	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD34—vascular cancer	3.53e-05	0.00385	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	3.5e-05	0.00381	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—WWTR1—vascular cancer	3.38e-05	0.00368	CbGpPWpGaD
Gefitinib—EGFR—Disease—WWTR1—vascular cancer	3.23e-05	0.00352	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—TSC2—vascular cancer	3.16e-05	0.00344	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	3.14e-05	0.00342	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—TSC2—vascular cancer	3.08e-05	0.00335	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—TSC2—vascular cancer	3.03e-05	0.0033	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TSC2—vascular cancer	2.87e-05	0.00312	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	2.86e-05	0.00312	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—TSC2—vascular cancer	2.63e-05	0.00286	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—WWTR1—vascular cancer	2.53e-05	0.00275	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD34—vascular cancer	2.36e-05	0.00257	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—TSC2—vascular cancer	2.31e-05	0.00251	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—WWTR1—vascular cancer	2.26e-05	0.00246	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TSC2—vascular cancer	2.23e-05	0.00243	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TSC2—vascular cancer	2.01e-05	0.00218	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—TSC2—vascular cancer	1.84e-05	0.002	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—WWTR1—vascular cancer	1.81e-05	0.00197	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—TSC2—vascular cancer	1.76e-05	0.00191	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—WWTR1—vascular cancer	1.71e-05	0.00186	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TSC2—vascular cancer	1.7e-05	0.00185	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—TSC2—vascular cancer	1.69e-05	0.00184	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TSC2—vascular cancer	1.56e-05	0.0017	CbGpPWpGaD
Gefitinib—ALB—Metabolism—WWTR1—vascular cancer	1.56e-05	0.0017	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TSC2—vascular cancer	1.53e-05	0.00167	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—HBA1—vascular cancer	1.41e-05	0.00154	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—WWTR1—vascular cancer	1.4e-05	0.00152	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—WWTR1—vascular cancer	1.37e-05	0.00149	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—WWTR1—vascular cancer	1.29e-05	0.0014	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—WWTR1—vascular cancer	1.28e-05	0.00139	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TSC2—vascular cancer	1.23e-05	0.00134	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TSC2—vascular cancer	1.19e-05	0.00129	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TSC2—vascular cancer	1.02e-05	0.00111	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HBA1—vascular cancer	1.01e-05	0.0011	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TSC2—vascular cancer	9.9e-06	0.00108	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HBA1—vascular cancer	9.57e-06	0.00104	CbGpPWpGaD
Gefitinib—EGFR—Disease—TSC2—vascular cancer	9.45e-06	0.00103	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HBA1—vascular cancer	8.72e-06	0.00095	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—WWTR1—vascular cancer	8.41e-06	0.000916	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HBA1—vascular cancer	7.83e-06	0.000853	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HBA1—vascular cancer	7.64e-06	0.000832	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HBA1—vascular cancer	7.2e-06	0.000784	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HBA1—vascular cancer	7.14e-06	0.000777	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSC2—vascular cancer	6.62e-06	0.000721	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HBA1—vascular cancer	4.71e-06	0.000513	CbGpPWpGaD
